Trelegy Ellipta is an inhalation powder containing a combination of fluticasone, umeclidinium, and vilanterol.
Fluticasone is a steroid that prevents the release of substances in the body that cause inflammation. Umeclidinium is an anticholinergic. Vilanterol is a bronchodilator. These medications work by relaxing muscles in the airways to improve breathing.
Trelegy Ellipta is used to improve symptoms and prevent bronchospasm in adults with COPD (chronic obstructive pulmonary disease), including bronchitis and emphysema.
Trelegy Ellipta is also used in adults to prevent and control symptoms of asthma for better breathing and to prevent symptoms such as wheezing.
Trelegy Elliptae is not for use in treating an asthma or bronchospasm attack.
Vilanterol when used alone may increase the risk of death in people with asthma. However, this risk is not increased when vilanterol is used in a combination product with fluticasone and umeclidinium.
